Supplementary Tables 1 - 3 from Pathway Analyses Identify <i>TGFBR2</i> as Potential Breast Cancer Susceptibility Gene: Results from a Consortium Study among Asians

Xiangyu Ma,Alicia Beeghly-Fadiel,Wei Lu,Jiajun Shi,Yong-Bing Xiang,Qiuyin Cai,Hongbing Shen,Chen-Yang Shen,Zefang Ren,Keitaro Matsuo,Ui Soon Khoo,Motoki Iwasaki,Jirong Long,Ben Zhang,Bu-Tian Ji,Ying Zheng,Wenjing Wang,Zhibin Hu,Yao Liu,Pei-Ei Wu,Ya-Lan Shieh,Shenming Wang,Xiaoming Xie,Hidemi Ito,Yoshio Kasuga,Kelvin Y.K. Chan,Hiroji Iwata,Shoichiro Tsugane,Yu-Tang Gao,Xiao Ou Shu,Harold L. Moses,Wei Zheng
DOI: https://doi.org/10.1158/1055-9965.22436139.v1
2023-01-01
Abstract:<p>PDF file, 199KB, Supplementary Table 1. TGF-β signaling pathway SNPs and breast cancer risk, Stage I. Supplementary Table 2. TGF-β signaling pathway variants showing an association with breast cancer risk (P value ≤0.05) in at least one genetic model, Stage 1. Supplementary Table 3. Results for TGF-β signaling pathway SNPs selected for Stage II evaluation (not presented in Table 3).</p>
What problem does this paper attempt to address?